About this trial
This epidemiologic research is being conducted as an observational prospective case series outcomes study of the use of advanced integrative specialty medical care and its effect on adult and pediatric patients with chronic or serious illnesses or mental health disorders.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
A new patient coming in for a first office call (FOC) or first consultation via telemedicine with an AIMS physician or advanced practice provider;
An established patient;
If over 18 years of age are able to understand study design adequately and provide signed informed consent to enrollment;
If younger than 18 years of age informed consent from a parent or guardian who is able to understand the study design adequately and provide signed informed consent for the pediatric patient.
Disqualifiers
Cannot read or understand English well enough to read and sign the consent form and complete the questionnaires;
Unwilling to participate in the AIMS Institute observational study.
Trial population
All patients who seek care at AIMS Institute and meet inclusion/exclusion criteria are eligible to participate in this study.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Health Related Quality of Life
Measure quality of life using GAD-7, PHQ-9, and short form questionnaire.
Secondary outcomes
Treatment
Describe treatments prescribed and provided by AIMS Institute physicians abstracted from chart review.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.